ISB News

Event: Cancer Think Tank

Cure First is hosting the forum “Cancer Think Tank.” Speakers include ISB’s Dr. Ilya Shmulevich and Dr. Brady Bernard.

Date: January 21, 2016
Time: 1-5:30 p.m. MED talks, breakout sessions, and panel discussion; 6-8 p.m. networking with wine and dinner
Why: To jump start innovative collaborations in cancer research with the goal to submit proposals for funding to accelerate the discovery of new, less toxic and targeted therapies.
Who: This event is for you if you are a practicing specialist and interested in any of the following specialties: clinical oncology, computational sciences, patient advocacy, pharmaceutical R&D, cancer research, and genetics.
Where: Kakao, 415 Westlake Ave N, Seattle, WA 98109
Speakers: list

Cure First is bringing together from a variety of disciplines including research, clinical, computational science, pharmaceutical science, healthcare investment, to share their work and vision about the realities of what precision medicine can bring to cancer patients. With new high throughput screening (HTS) capabilities, we can now test hundreds of genes and target those that are cancer specific for more effective, less toxic therapies. Cancer Think Tank will provide a forum for experts to consider these and other approaches to identify new possibilities and further our understanding of how to kill cancer.

Agenda: New ideas and insights into potentially disruptive science and technology will b e shared through MED Talk presentations. In small working groups, facilitators will ask for ideas and examples of what can be done to develop new approaches for treating cancer. Research themes will surface from group interactions and be shared with the larger group for further investigation. From this exchange of ideas, topics for grants will be identified and sent out after the event to Cancer Think Tank participants for review. The afternoon will close with social networking, dinner and drinks.

Results: Funding for specific initiatives emerging from the conference will be pursued in the months following. Participants interested in working with other specialists will be invited to write segments of grant applications using a structured approach for faster development and strategic submission to funding institutions such as the NIH and NCI.

REGISTER

 

Related Articles

  • New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines

    Members of ISB’s Heath Lab and their collaborators have developed a way to sensitively detect and analyze neoantigen-specific T-cell populations from tumors and blood. This promising development may have implications for creating targeted, individual-specific cancer vaccines.

  • The Cancer Paradox

    ISB’s Dr. Sui Huang uses the theory of complex systems and applies it to cancer research. In this video Q&A, he discusses the cancer paradox and highlights the importance of understanding the mechanism of what cancer treatments can backfire in order to open a new avenue for therapy and treatments.

  • Dr. Wei Wei Awarded CARE Grant

    The Andy Hill Cancer Research Endowment (CARE) is a public-private partnership that supports cancer research in Washington state. CARE announced ISB Assistant Professor Dr. Wei Wei as a CARE Fund Distinguished Researcher and awarded him $500,000.

Show More Articles